Drug Development and Industrial Pharmacy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.6 | Q3 | 45.5% | 0.402 | Q2 | 53.5% |
| 2024 | 2.2 | Q3 | 41.1% | 0.451 | Q2 | 58.9% |
| 2023 | 2.4 | Q3 | 48.0% | 0.475 | Q2 | 63.2% |
| 2022 | 3.4 | Q2 | 62.5% | 0.474 | Q2 | 64.7% |
| 2021 | 3.7 | Q2 | 63.4% | 0.566 | Q2 | 71.0% |
| 2020 | — | — | 0.628 | Q2 | 73.1% | |
| 2019 | — | — | 0.521 | Q2 | 68.7% | |
| 2018 | — | — | 0.608 | Q2 | 71.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1520-5762
ISSN
0363-9045
region
Western Europe
coverage
1974, 1976-2026